|
⚲
|
| Keyboard |
| Brister Mark
✚
|
|
|---|---|
| CIK # | 0001323223 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001323223] | |
| 4 | [0001323223] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Brister Mark | |
| Obalon Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Obalon Therapeutics Inc OBLN
Restricted Stock Units · derivative
|
2020-01-24 | Grant | 110,281 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2019-10-25 | Grant | 13,000 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Warrants (Right to Buy) · derivative
|
2019-08-06 | Buy | 3,750 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2019-08-06 | Buy | 5,000 | $4.00 | 20,000 |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2019-07-23 | Grant | 35,000 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Stock Option (Right to Buy) · derivative
|
2019-01-02 | Grant | 100,000 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2018-08-23 | Grant | 107,142 | $1.82 | 194,998 |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2018-04-30 | Grant | 2,622 | $3.27 | 8,574 |
|
Obalon Therapeutics Inc OBLN
Common Stock (Restricted Stock Award)
|
2018-01-02 | Grant | 65,000 | $0.00 | |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2017-10-31 | Grant | 1,860 | $7.17 | 13,336 |
|
Obalon Therapeutics Inc OBLN
Common Stock
|
2017-04-30 | Grant | 1,550 | $9.03 | 13,996 |
|
Obalon Therapeutics Inc OBLN
Stock Option (right to buy) · derivative
|
2016-11-09 | Grant | 90,000 | $0.00 |